The recent report published in Drug and Therapeutics Bulletin* reviewed the available research on the use of supplements in pregnancy and highlighted strong evidence supporting the use of Folic Acid in pregnancy – confirming the Department of Health’s recommendation that all pregnant women should take a daily tablet of 400mcg Folic Acid.
Sadly, many women are still not aware of the vital importance of taking additional Folic Acid to protect the unborn baby from Spina Bifida and other neural tube defects and retailers can play a vital role in raising awareness of this important nutrient. Studies have shown that taking an additional 400mcg of Folic Acid every day – the same amount found in a single dose of Preconceive – can reduce the chance of a baby being born with neural tube defects by as much as 70%**.
The neural tube develops very early in pregnancy (even before pregnancy is confirmed) so it is important women start taking Lanes Preconceive as soon as they start trying for a baby rather than waiting for pregnancy to be confirmed. Indeed many doctors recommend that all women who might become pregnant routinely take a Folic Acid supplement.
As a B vitamin, Folic Acid is found in foods such as green vegetables and fruits, however diet alone cannot provide additional amount needed by pregnant women. It’s therefore recommended that women start taking Preconceive as soon as they start planning to get pregnant and until the end of the third month.
In 1930, Gilbert Lane established a thriving and prosperous family business. Gilbert was interested in all aspects of health and nutrition and he developed a wide range of effective remedies to treat many common ailments. Today LanesHealth remains a family owned business, passionately manufacturing and supplying a range of OTC medicines that are sold around the globe.
*Vitamin supplementation in pregnancy. Drug and Therapeutics Bulletin. 2016; 54:7 81-84 Published Online First: 11 July 2016
** Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of medical council vitamin study. Lancet 1999; 338 (8760): 131-7
Tel: 01452 524012